Orbital Global is a member of a new Horizon Europe research and innovation consortium, which aims to personalise prevention and treatment of cardiovascular diseases. Led by Novo Nordisk and Maastricht University, the ‘iCARE4CVD’ (individualised care from early risk of cardiovascular disease to established heart failure) consortium is formed of thirty-three leading international partners from civil society, academia, and industry.
Read MoreBy Paul Gampe, Chief Technology Officer, Console Connect.
Read MoreBy Omer Grossman, Chief Information Officer, CyberArk.
Read MoreBy Anders Billesø Beck, Vice President Strategy & Innovation, Universal Robots.
Read MoreBy Gaurav Dhillon, CEO of SnapLogic.
Read MoreNew AI Model Building Platform and a suite of innovative cloud products launched to cater for the surging demand among customers and developers.
Read More